L&K Biomed

엘앤케이바이오 · 156100

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$85.5M (₩118B)

Overview

L&K Biomed makes spinal implants, metal screws, plates, and cages surgically inserted into the spine to stabilize or correct conditions such as degeneration, stenosis, fractures, and scoliosis.

Its products are used by orthopedic and neurosurgeons and fall into the highest-risk regulated category for implantable medical devices in Korea. Listed on KOSDAQ, Korea's tech and small-cap board, the company covers the full product range for spinal surgery, spanning both cervical (neck) and thoracolumbar (mid-to-lower back) applications.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$28.2M

▲ +7.8% YoY

Operating profit · FY2025

US$518.2K

▼ −76.8% YoY

Net income · FY2025

−US$12.2M

Turned to loss

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$21.7M(₩29.9B)	US$26.2M(₩36.1B)	US$28.2M(₩38.9B)
Operating profit	US$1.5M(₩2B)	US$2.2M(₩3.1B)	US$518.2K(₩715.1M)
Net income	−US$3.8M(−₩5.2B)	US$6.6M(₩9.2B)	−US$12.2M(−₩16.8B)

Revenue

FY2023US$21.7M
FY2024US$26.2M
FY2025US$28.2M

Operating profit

FY2023US$1.5M
FY2024US$2.2M
FY2025US$518.2K

Net income

FY2023−US$3.8M
FY2024US$6.6M
FY2025−US$12.2M

Key ratios (FY2025)

ROE

-43.5%

Debt/Eq

116.1%

Op. margin

1.8%

Net margin

-43.1%

Rev. YoY

▲ +7.8%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?